Polycystic Ovaries Research Today is a free monthly online journal that collates and summarizes the latest research about Polycystic Ovaries, including details on treatment, symptoms, polycystic ovary syndrome, infertility.

Volume 2 (2005), Issue 3 (March)

1. Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia.
   J Lab Clin Med, 145(2): 72-82. [Abstract] [Full-text]
2. Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome.
   Eur J Endocrinol, 152(2): 269-75. [Abstract] [Full-text]
3. Evidence for altered adipocyte function in polycystic ovary syndrome.
   Eur J Endocrinol, 152(3): 389-94. [Abstract] [Full-text]
4. Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients.
   J Clin Endocrinol Metab, 90(3): 1398-406. [Abstract] [Full-text]
5. Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome.
   J Clin Endocrinol Metab, 90(3): 1720-7. [Abstract] [Full-text]
6. Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome.
   J Clin Endocrinol Metab, 90(3): 1360-5. [Abstract] [Full-text]
7. Effect of Implanon on insulin resistance in women with Polycystic Ovary Syndrome.
   Aust N Z J Obstet Gynaecol, 45(2): 155-8. [Abstract] [Full-text]
8. Thiazolidinediones for treatment of polycystic ovary syndrome.
   Pharmacotherapy, 25(2): 244-52. [Abstract] [Full-text]
9. Role of ovary and adrenal glands in hyperandrogenemia in patients with polycystic ovary syndrome.
   Exp Clin Endocrinol Diabetes, 113(2): 115-21. [Abstract] [Full-text]
10. Laparoscopic ovarian drilling in the treatment of polycystic ovary syndrome: how many punctures per ovary are needed to improve the reproductive outcome?
    J Obstet Gynaecol Res, 31(2): 115-9. [Abstract] [Full-text]
11. Influence of leptin, androgens and insulin sensitivity on increased GH response to clonidine in lean patients with polycystic ovary syndrome.
    Horm Metab Res, 37(2): 94-8. [Abstract] [Full-text]
12. Polycystic ovary syndrome in post-menopausal women--marker of the metabolic syndrome.
    Maturitas, 50(4): 331-6. [Abstract] [Full-text]
13. Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life.
    Ambul Pediatr, 5(2): 107-11. [Abstract] [Full-text]
14. No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome.
    Hum Reprod, 20(4): 965-9. [Abstract] [Full-text]
15. Predictors for treatment failure after laparoscopic electrocautery of the ovaries in women with clomiphene citrate resistant polycystic ovary syndrome.
    Hum Reprod, 20(4): 900-5. [Abstract] [Full-text]
16. Endometrial fluid visualized through ultrasonography during ovarian stimulation in IVF cycles impairs the outcome in tubal factor, but not PCOS, patients.
    Hum Reprod, 20(4): 906-9. [Abstract] [Full-text]
17. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
    Hum Reprod, 20(4): 894-9. [Abstract] [Full-text]
18. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome.
    Endocr Rev, 26(2): 251-82. [Abstract] [Full-text]
19. Ovarian expression of alpha (1)- and beta (2)-adrenoceptors and p75 neurotrophin receptors in rats with steroid-induced polycystic ovaries.
    Auton Neurosci, 118(1): 79-87. [Abstract] [Full-text]

© 2004-2008 Polycystic Ovaries Research Today. All Rights Reserved.